AI Articles and Analysis about Generative AI

Explainable AI models are essential in pharmaceutical R&D because they provide transparency and understanding of how AI-driven predictions are made. In drug discovery and development, stakeholders, including researchers, regulatory bodies, and healthcare professionals, need to trust and understand AI models' outputs to make informed decisions. Without explainability, AI models can be seen as "black boxes," leading to skepticism and reluctance to adopt these technologies in critical decision-making processes. 

KeyBank is a financial services institution with a rich history dating back to 1825 and headquartered in Cleveland, Ohio. With 17,000 employees, operations across 15 states, and assets totaling $187 billion, KeyBank's commitment to innovation is evident in its strategic application of AI technologies to enhance both workforce management and customer service. 

Nestlé is a global leader in the food and beverage industry, operating across 189 countries with a workforce of over 339,000 employees. Formed in 1905 and headquartered in Vevey, Switzerland, it is the largest publicly held global food company, according to Forbes's Global 500 list, with over $98 billion in sales just last year. 

Like much of the financial services space broadly, the insurance industry is growing interested in adopting AI. The technology holds immense potential to revolutionize insurance, enhancing efficiency and accuracy across various processes such as claims and underwriting. However, concerns surrounding data privacy and integration complexities have prompted a measured approach among industry leaders.

Nationwide Mutual Insurance Company, commonly known as Nationwide, is a primary US insurance and financial services company headquartered in Columbus, Ohio.

AstraZeneca is a global biopharmaceutical company that researches, develops, manufactures, and markets prescription drugs and vaccines. Its key therapeutic areas include oncology, cardiovascular, renal, metabolism, respiratory, and immunology. In 2022, the company reported revenue of $42.67 billion and a profit of $4.08 billion. The company has a significant global presence, employing around 89,900 people across more than 60 countries as of 2023.

This interview analysis is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

The asset management industry is going through several challenges, like the prolonged low-interest rate environment, dwindling margins, increased cost pressures, and squeezed profitability. Meanwhile, exponential growth in data volumes has overwhelmed legacy data management systems and analytical tools, making it tiring to process and extract valuable insights from the deluge of information.